RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models. - Grether U; Foxton RH; Gruener S; Korn C; Kimbara A; Osterwald A; Zirwes E; Uhles S; Thoele J; Colé N; Rogers-Evans M; Röver S; et al. (Frontiers in pharmacology, 2024)